What to Expect from the Report
The 2022 ESMO Annual Meeting is over, but the connections, data, and information shared at the conference will stay with us. Our team of analysts have carefully screened all the ESMO 2022 abstracts and identified 18 (17 clinical, 1 preclinical) abstracts relating to Cancer Vaccine drugs and trials, and added them to the Beacon Cancer Vaccine database.
This report encompasses a detailed analysis of the 18 abstracts in the cancer vaccine space, including; clinical abstracts by phase, trial outline summaries and preclinical and clinical abstract summaries.
You will also find a full summary of all 18 cancer vaccine abstracts ordered by; therapeutic class/vaccine type, antigen class and disease indication. The abstract summaries include the following data; the name and link to the drug (on Beacon), trial sponsor/developer, abstract/ trial ID, phase, disease indication and description/dosing.